http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090129230-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441e2d5f9ba85341a7235bf0c40ddbe8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate | 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6339b591ffa73ea02f9b02d5539492ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a03e7d93183a43cf5fb4ce1d3b29422e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bc6513fb1a7f016c94062562c143953 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b21d9222d77ad7765da405d6d8e83f |
| publicationDate | 2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090129230-A |
| titleOfInvention | Wound Treatment Method Using Human Embryonic Stem Cell-Derived Vascular Progenitor Cells |
| abstract | The present invention (a) culturing the vascular progenitor cells derived from embryonic stem cells for transplantation; (b) providing a wound treatment method using the embryonic stem cell-derived vascular progenitor cells, comprising transplanting the cultured embryonic stem cell-derived vascular progenitor cells into the skin of a mammal.n n n The wound treatment method of the present invention eliminates limitations on cell sources by using human embryonic stem cell-derived vascular precursor cells, which are new cell sources of vascular precursor cells known to be effective in treating existing wounds. It is effective to greatly improve the wound treatment efficiency than conventional adult stem cell-derived vascular precursor cells. In addition, according to the wound treatment method of the present invention, transplanted human embryonic stem cell-derived vascular progenitor cells promote angiogenesis to facilitate the transfer of factors necessary for wound healing, thereby increasing the synthesis of collagen required for wound healing. The newly formed collagen layer creates an environment in which stromal cells, skin cells, and the like, which are necessary for wound healing, can be more easily grown, thereby shortening the wound healing period. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013108949-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180063817-A |
| priorityDate | 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.